This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodrum, F. D.
Right arrow Articles by Ornelles, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodrum, F. D.
Right arrow Articles by Ornelles, D. A.

 Previous Article  |  Next Article 

Journal of Virology, December 1998, p. 9479-9490, Vol. 72, No. 12
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

p53 Status Does Not Determine Outcome of E1B 55-Kilodalton Mutant Adenovirus Lytic Infection

Felicia D. Goodrum and David A. Ornelles*

Molecular Genetics Program and Department of Microbiology and Immunology, Wake Forest University School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157

Received 16 June 1998/Accepted 20 August 1998

The ability of the adenovirus type 5 E1B 55-kDa mutants dl1520 and dl338 to replicate efficiently and independently of the cell cycle, to synthesis viral DNA, and to lyse infected cells did not correlate with the status of p53 in seven cell lines examined. Rather, cell cycle-independent replication and virus-induced cell killing correlated with permissivity to viral replication. This correlation extended to S-phase HeLa cells, which were more susceptible to virus-induced cell killing by the E1B 55-kDa mutant virus than HeLa cells infected during G1. Wild-type p53 had only a modest effect on E1B mutant virus yields in H1299 cells expressing a temperature-sensitive p53 allele. The defect in E1B 55-kDa mutant virus replication resulting from reduced temperature was as much as 10-fold greater than the defect due to p53 function. At 39°C, the E1B 55-kDa mutant viruses produced wild-type yields of virus and replicated independently of the cell cycle. In addition, the E1B 55-kDa mutant viruses directed the synthesis of late viral proteins to levels equivalent to the wild-type virus level at 39°C. We have previously shown that the defect in mutant virus replication can also be overcome by infecting HeLa cells during S phase. Taken together, these results indicate that the capacity of the E1B 55-kDa mutant virus to replicate independently of the cell cycle does not correlate with the status of p53 but is determined by yet unidentified mechanisms. The cold-sensitive nature of the defect of the E1B 55-kDa mutant virus in both late gene expression and cell cycle-independent replication leads us to speculate that these functions of the E1B 55-kDa protein may be linked.

* Corresponding author. Mailing address: Department of Microbiology and Immunology, Wake Forest University School of Medicine, Bowman Gray Campus, Winston-Salem, NC 27157-1064. Phone: (336) 716-9332. Fax: (336) 716-9928. E-mail: ornelles{at}wfubmc.edu.

Journal of Virology, December 1998, p. 9479-9490, Vol. 72, No. 12
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Gurlevik, E., Woller, N., Schache, P., Malek, N. P., Wirth, T. C., Zender, L., Manns, M. P., Kubicka, S., Kuhnel, F. (2009). p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication. Nucleic Acids Res 37: e84-e84 [Abstract] [Full Text]  
  • Blackford, A. N., Grand, R. J. A. (2009). Adenovirus E1B 55-Kilodalton Protein: Multiple Roles in Viral Infection and Cell Transformation. J. Virol. 83: 4000-4012 [Full Text]  
  • Thomas, M. A., Broughton, R. S., Goodrum, F. D., Ornelles, D. A. (2009). E4orf1 Limits the Oncolytic Potential of the E1B-55K Deletion Mutant Adenovirus. J. Virol. 83: 2406-2416 [Abstract] [Full Text]  
  • Zheng, X., Rao, X.-M., Gomez-Gutierrez, J. G., Hao, H., McMasters, K. M., Zhou, H. S. (2008). Adenovirus E1B55K Region Is Required To Enhance Cyclin E Expression for Efficient Viral DNA Replication. J. Virol. 82: 3415-3427 [Abstract] [Full Text]  
  • Woo, J. L., Berk, A. J. (2007). Adenovirus Ubiquitin-Protein Ligase Stimulates Viral Late mRNA Nuclear Export. J. Virol. 81: 575-587 [Abstract] [Full Text]  
  • Hiraoka, K., Kimura, T., Logg, C. R., Kasahara, N. (2006). Tumor-Selective Gene Expression in a Hepatic Metastasis Model after Locoregional Delivery of a Replication-Competent Retrovirus Vector. Clin. Cancer Res. 12: 7108-7116 [Abstract] [Full Text]  
  • Gonzalez, R., Huang, W., Finnen, R., Bragg, C., Flint, S. J. (2006). Adenovirus E1B 55-Kilodalton Protein Is Required for both Regulation of mRNA Export and Efficient Entry into the Late Phase of Infection in Normal Human Fibroblasts. J. Virol. 80: 964-974 [Abstract] [Full Text]  
  • Thorne, S. H., Brooks, G., Lee, Y.-L., Au, T., Eng, L. F., Reid, T. (2005). Effects of Febrile Temperature on Adenoviral Infection and Replication: Implications for Viral Therapy of Cancer. J. Virol. 79: 581-591 [Abstract] [Full Text]  
  • Shepard, R. N., Ornelles, D. A. (2004). Diverse Roles for E4orf3 at Late Times of Infection Revealed in an E1B 55-Kilodalton Protein Mutant Background. J. Virol. 78: 9924-9935 [Abstract] [Full Text]  
  • Chu, R. L., Post, D. E., Khuri, F. R., Van Meir, E. G. (2004). Use of Replicating Oncolytic Adenoviruses in Combination Therapy for Cancer. Clin. Cancer Res. 10: 5299-5312 [Abstract] [Full Text]  
  • Hobom, U., Dobbelstein, M. (2004). E1B-55-Kilodalton Protein Is Not Required To Block p53-Induced Transcription during Adenovirus Infection. J. Virol. 78: 7685-7697 [Abstract] [Full Text]  
  • McNees, A. L., Mahr, J. A., Ornelles, D., Gooding, L. R. (2004). Postinternalization Inhibition of Adenovirus Gene Expression and Infectious Virus Production in Human T-Cell Lines. J. Virol. 78: 6955-6966 [Abstract] [Full Text]  
  • Maemondo, M., Saijo, Y., Narumi, K., Kikuchi, T., Usui, K., Tazawa, R., Matsumoto, K., Nakamura, T., Sasaki, K., Takahashi, M., Niitsu, Y., Nukiwa, T. (2004). Gene Therapy with Secretory Leukoprotease Inhibitor Promoter-Controlled Replication-Competent Adenovirus for Non-Small Cell Lung Cancer. Cancer Res. 64: 4611-4620 [Abstract] [Full Text]  
  • Barzon, L., Boscaro, M., Palu, G. (2004). Endocrine Aspects of Cancer Gene Therapy. Endocr. Rev. 25: 1-44 [Abstract] [Full Text]  
  • Hann, B., Balmain, A. (2003). Replication of an E1B 55-Kilodalton Protein-Deficient Adenovirus (ONYX-015) Is Restored by Gain-of-Function Rather than Loss-of-Function p53 Mutants. J. Virol. 77: 11588-11595 [Abstract] [Full Text]  
  • Moon, C., Oh, Y., Roth, J. A. (2003). Current Status of Gene Therapy for Lung Cancer and Head and Neck Cancer. Clin. Cancer Res. 9: 5055-5067 [Abstract] [Full Text]  
  • Portella, G., Pacelli, R., Libertini, S., Cella, L., Vecchio, G., Salvatore, M., Fusco, A. (2003). ONYX-015 Enhances Radiation-Induced Death of Human Anaplastic Thyroid Carcinoma Cells. J. Clin. Endocrinol. Metab. 88: 5027-5032 [Abstract] [Full Text]  
  • Fukuda, K., Abei, M., Ugai, H., Seo, E., Wakayama, M., Murata, T., Todoroki, T., Tanaka, N., Hamada, H., Yokoyama, K. K. (2003). E1A, E1B Double-restricted Adenovirus for Oncolytic Gene Therapy of Gallbladder Cancer. Cancer Res. 63: 4434-4440 [Abstract] [Full Text]  
  • Chastain-Moore, A. M., Roberts, T., Trott, D. A., Newbold, R. F., Ornelles, D. A. (2003). An Activity Associated with Human Chromosome 21 Permits Nuclear Colocalization of the Adenovirus E1B-55K and E4orf6 Proteins and Promotes Viral Late Gene Expression. J. Virol. 77: 8087-8098 [Abstract] [Full Text]  
  • Wadler, S., Yu, B., Tan, J.-Y., Kaleya, R., Rozenblit, A., Makower, D., Edelman, M., Lane, M., Hyjek, E., Horwitz, M. (2003). Persistent Replication of the Modified Chimeric Adenovirus ONYX-015 in both Tumor and Stromal Cells from a Patient with Gall Bladder Carcinoma Implants. Clin. Cancer Res. 9: 33-43 [Abstract] [Full Text]  
  • Edwards, S. J., Dix, B. R., Myers, C. J., Dobson-Le, D., Huschtscha, L., Hibma, M., Royds, J., Braithwaite, A. W. (2002). Evidence that Replication of the Antitumor Adenovirus ONYX-015 Is Not Controlled by the p53 and p14ARF Tumor Suppressor Genes. J. Virol. 76: 12483-12490 [Abstract] [Full Text]  
  • Reid, T., Galanis, E., Abbruzzese, J., Sze, D., Wein, L. M., Andrews, J., Randlev, B., Heise, C., Uprichard, M., Hatfield, M., Rome, L., Rubin, J., Kirn, D. (2002). Hepatic Arterial Infusion of a Replication-selective Oncolytic Adenovirus (dl1520): Phase II Viral, Immunologic, and Clinical Endpoints. Cancer Res. 62: 6070-6079 [Abstract] [Full Text]  
  • Bernt, K., Liang, M., Ye, X., Ni, S., Li, Z.-Y., Ye, S. L., Hu, F., Lieber, A. (2002). A New Type of Adenovirus Vector That Utilizes Homologous Recombination To Achieve Tumor-Specific Replication. J. Virol. 76: 10994-11002 [Abstract] [Full Text]  
  • Barnes, M. N., Coolidge, C. J., Hemminki, A., Alvarez, R. D., Curiel, D. T. (2002). Conditionally Replicative Adenoviruses for Ovarian Cancer Therapy. Molecular Cancer Therapeutics 1: 435-439 [Abstract] [Full Text]  
  • Mullen, J. T., Tanabe, K. K. (2002). Viral Oncolysis. The Oncologist 7: 106-119 [Abstract] [Full Text]  
  • Gonzalez, R. A., Flint, S. J. (2002). Effects of Mutations in the Adenoviral E1B 55-Kilodalton Protein Coding Sequence on Viral Late mRNA Metabolism. J. Virol. 76: 4507-4519 [Abstract] [Full Text]  
  • Vasey, P. A., Shulman, L. N., Campos, S., Davis, J., Gore, M., Johnston, S., Kirn, D. H., O'Neill, V., Siddiqui, N., Seiden, M. V., Kaye, S. B. (2002). Phase I Trial of Intraperitoneal Injection of the E1B-55-kd-Gene-Deleted Adenovirus ONYX-015 (dl1520) Given on Days 1 Through 5 Every 3 Weeks in Patients With Recurrent/Refractory Epithelial Ovarian Cancer. JCO 20: 1562-1569 [Abstract] [Full Text]  
  • Holm, P. S., Bergmann, S., Jurchott, K., Lage, H., Brand, K., Ladhoff, A., Mantwill, K., Curiel, D. T., Dobbelstein, M., Dietel, M., Gansbacher, B., Royer, H.-D. (2002). YB-1 Relocates to the Nucleus in Adenovirus-infected Cells and Facilitates Viral Replication by Inducing E2 Gene Expression through the E2 Late Promoter. J. Biol. Chem. 277: 10427-10434 [Abstract] [Full Text]  
  • Ring, C. J. A. (2002). Cytolytic viruses as potential anti-cancer agents. J. Gen. Virol. 83: 491-502 [Abstract] [Full Text]  
  • Haviv, Y. S., Takayama, K., Glasgow, J. N., Blackwell, J. L., Wang, M., Lei, X., Curiel, D. T. (2002). A Model System for the Design of Armed Replicating Adenoviruses Using p53 as a Candidate Transgene. Molecular Cancer Therapeutics 1: 321-328 [Abstract] [Full Text]  
  • Orlando, J. S., Ornelles, D. A. (2002). E4orf6 Variants with Separate Abilities To Augment Adenovirus Replication and Direct Nuclear Localization of the E1B 55-Kilodalton Protein. J. Virol. 76: 1475-1487 [Abstract] [Full Text]  
  • Geoerger, B., Grill, J., Opolon, P., Morizet, J., Aubert, G., Terrier-Lacombe, M.-J., Bressac de-Paillerets, B., Barrois, M., Feunteun, J., Kirn, D. H., Vassal, G. (2002). Oncolytic Activity of the E1B-55 kDa-deleted Adenovirus ONYX-015 Is Independent of Cellular p53 Status in Human Malignant Glioma Xenografts. Cancer Res. 62: 764-772 [Abstract] [Full Text]  
  • Haviv, Y. S., Blackwell, J. L., Li, H., Wang, M., Lei, X., Curiel, D. T. (2001). Heat Shock and Heat Shock Protein 70i Enhance the Oncolytic Effect of Replicative Adenovirus. Cancer Res. 61: 8361-8365 [Abstract] [Full Text]  
  • Endter, C., Kzhyshkowska, J., Stauber, R., Dobner, T. (2001). SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc. Natl. Acad. Sci. USA 10.1073/pnas.191361798v1 [Abstract] [Full Text]  
  • Andreu, T., Ebensperger, C., Westphal, E.-M., Klenner, T., Stewart, A. F., Westhof, A., Muller, P., Knaus, R., von Melchner, H. (2001). Self-deleting Suicide Vectors (SDSV): Selective Killing of p53-deficient Cancer Cells. Cancer Res. 61: 6925-6930 [Abstract] [Full Text]  
  • Koch, P., Gatfield, J., Lober, C., Hobom, U., Lenz-Stoppler, C., Roth, J., Dobbelstein, M. (2001). Efficient Replication of Adenovirus Despite the Overexpression of Active and Nondegradable p53. Cancer Res. 61: 5941-5947 [Abstract] [Full Text]  
  • Dix, B. R., Edwards, S. J., Braithwaite, A. W. (2001). Does the Antitumor Adenovirus ONYX-015/dl1520 Selectively Target Cells Defective in the p53 Pathway?. J. Virol. 75: 5443-5447 [Full Text]  
  • Shen, Y., Kitzes, G., Nye, J. A., Fattaey, A., Hermiston, T. (2001). Analyses of Single-Amino-Acid Substitution Mutants of Adenovirus Type 5 E1B-55K Protein. J. Virol. 75: 4297-4307 [Abstract] [Full Text]  
  • Doronin, K., Kuppuswamy, M., Toth, K., Tollefson, A. E., Krajcsi, P., Krougliak, V., Wold, W. S. M. (2001). Tissue-Specific, Tumor-Selective, Replication-Competent Adenovirus Vector for Cancer Gene Therapy. J. Virol. 75: 3314-3324 [Abstract] [Full Text]  
  • Brunori, M., Malerba, M., Kashiwazaki, H., Iggo, R. (2001). Replicating Adenoviruses That Target Tumors with Constitutive Activation of the wnt Signaling Pathway. J. Virol. 75: 2857-2865 [Abstract] [Full Text]  
  • Nemunaitis, J., Khuri, F., Ganly, I., Arseneau, J., Posner, M., Vokes, E., Kuhn, J., McCarty, T., Landers, S., Blackburn, A., Romel, L., Randlev, B., Kaye, S., Kirn, D. (2001). Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer. JCO 19: 289-298 [Abstract] [Full Text]  
  • Nemunaitis, J., Ganly, I., Khuri, F., Arseneau, J., Kuhn, J., McCarty, T., Landers, S., Maples, P., Romel, L., Randlev, B., Reid, T., Kaye, S., Kirn, D. (2000). Selective Replication and Oncolysis in p53 Mutant Tumors with ONYX-015, an E1B-55kD Gene-deleted Adenovirus, in Patients with Advanced Head and Neck Cancer: A Phase II Trial. Cancer Res. 60: 6359-6366 [Abstract] [Full Text]  
  • Curiel, D. T. (2000). The Development of Conditionally Replicative Adenoviruses for Cancer Therapy. Clin. Cancer Res. 6: 3395-3399 [Abstract] [Full Text]  
  • Wildner, O., Morris, J. C. (2000). The Role of the E1B 55 kDa Gene Product in Oncolytic Adenoviral Vectors Expressing Herpes Simplex Virus-tk: Assessment of Antitumor Efficacy and Toxicity. Cancer Res. 60: 4167-4174 [Abstract] [Full Text]  
  • Doronin, K., Toth, K., Kuppuswamy, M., Ward, P., Tollefson, A. E., Wold, W. S. M. (2000). Tumor-Specific, Replication-Competent Adenovirus Vectors Overexpressing the Adenovirus Death Protein. J. Virol. 74: 6147-6155 [Abstract] [Full Text]  
  • Dix, B. R., O’Carroll, S. J., Myers, C. J., Edwards, S. J., Braithwaite, A. W. (2000). Efficient Induction of Cell Death by Adenoviruses Requires Binding of E1B55k and p53. Cancer Res. 60: 2666-2672 [Abstract] [Full Text]  
  • Rogulski, K. R., Freytag, S. O., Zhang, K., Gilbert, J. D., Paielli, D. L., Kim, J. H., Heise, C. C., Kirn, D. H. (2000). In Vivo Antitumor Activity of ONYX-015 Is Influenced by p53 Status and Is Augmented by Radiotherapy. Cancer Res. 60: 1193-1196 [Abstract] [Full Text]  
  • YOON, S. S., NAKAMURA, H., CARROLL, N. M., BODE, B. P., CHIOCCA, E. A., TANABE, K. K. (2000). An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma. FASEB J. 14: 301-311 [Abstract] [Full Text]  
  • You, L., Yang, C.-T., Jablons, D. M. (2000). ONYX-015 Works Synergistically with Chemotherapy in Lung Cancer Cell Lines and Primary Cultures Freshly Made from Lung Cancer Patients. Cancer Res. 60: 1009-1013 [Abstract] [Full Text]  
  • Weigel, S., Dobbelstein, M. (2000). The Nuclear Export Signal within the E4orf6 Protein of Adenovirus Type 5 Supports Virus Replication and Cytoplasmic Accumulation of Viral mRNA. J. Virol. 74: 764-772 [Abstract] [Full Text]  
  • Goodrum, F. D., Ornelles, D. A. (1999). Roles for the E4 orf6, orf3, and E1B 55-Kilodalton Proteins in Cell Cycle-Independent Adenovirus Replication. J. Virol. 73: 7474-7488 [Abstract] [Full Text]  
  • Chung, R. Y., Saeki, Y., Chiocca, E. A. (1999). B-myb Promoter Retargeting of Herpes Simplex Virus gamma 34.5 Gene-Mediated Virulence toward Tumor and Cycling Cells. J. Virol. 73: 7556-7564 [Abstract] [Full Text]  
  • Harada, J. N., Berk, A. J. (1999). p53-Independent and -Dependent Requirements for E1B-55K in Adenovirus Type 5 Replication. J. Virol. 73: 5333-5344 [Abstract] [Full Text]  
  • Shinoura, N., Yoshida, Y., Tsunoda, R., Ohashi, M., Zhang, W., Asai, A., Kirino, T., Hamada, H. (1999). Highly Augmented Cytopathic Effect of a Fiber-mutant E1B-defective Adenovirus for Gene Therapy of Gliomas. Cancer Res. 59: 3411-3416 [Abstract] [Full Text]  
  • Avgeropoulos, N. G., Batchelor, T. T. (1999). New Treatment Strategies for Malignant Gliomas. The Oncologist 4: 209-224 [Abstract] [Full Text]  
  • Advani, S. J., Chung, S.-M., Yan, S. Y., Gillespie, G. Y., Markert, J. M., Whitley, R. J., Roizman, B., Weichselbaum, R. R. (1999). Replication-competent, Nonneuroinvasive Genetically Engineered Herpes Virus Is Highly Effective in the Treatment of Therapy-resistant Experimental Human Tumors. Cancer Res. 59: 2055-2058 [Abstract] [Full Text]  
  • Yu, D.-C., Sakamoto, G. T., Henderson, D. R. (1999). Identification of the Transcriptional Regulatory Sequences of Human Kallikrein 2 and Their Use in the Construction of Calydon Virus 764, an Attenuated Replication Competent Adenovirus for Prostate Cancer Therapy. Cancer Res. 59: 1498-1504 [Abstract] [Full Text]  
  • Endter, C., Kzhyshkowska, J., Stauber, R., Dobner, T. (2001). SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc. Natl. Acad. Sci. USA 98: 11312-11317 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»